DK0870508T3 - Influenzavaccine - Google Patents

Influenzavaccine

Info

Publication number: DK0870508T3
Authority: DK; Denmark
Prior art keywords: influenza vaccine; influenza; vaccine
Prior art date: 1997-04-09

Application number

DK98201056T

Other languages

Danish (da)

English (en)

Inventor

Scharrenburg Gustaaf J M Van

Rudi Brands

Original Assignee

Duphar Int Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-09

Filing date

1998-04-02

Publication date

2000-11-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228174&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0870508(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-04-02 Application filed by Duphar Int Res filed Critical Duphar Int Res

2000-11-20 Application granted granted Critical

2000-11-20 Publication of DK0870508T3 publication Critical patent/DK0870508T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DK98201056T 1997-04-09 1998-04-02 Influenzavaccine DK0870508T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97201007		1997-04-09

Publications (1)

Publication Number	Publication Date
DK0870508T3 true DK0870508T3 (da)	2000-11-20

Family

ID=8228174

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98201056T DK0870508T3 (da)	1997-04-09	1998-04-02	Influenzavaccine

Country Status (31)

Country	Link
US (1)	US5948410A (de)
EP (1)	EP0870508B1 (de)
JP (1)	JP5258127B2 (de)
KR (1)	KR100593235B1 (de)
CN (1)	CN1138564C (de)
AR (1)	AR011216A1 (de)
AT (1)	ATE197406T1 (de)
AU (1)	AU728939B2 (de)
BR (1)	BR9801015A (de)
CA (1)	CA2234208C (de)
CZ (1)	CZ297492B6 (de)
DE (2)	DE69800383T2 (de)
DK (1)	DK0870508T3 (de)
DZ (1)	DZ2462A1 (de)
ES (1)	ES2129386T3 (de)
GR (2)	GR990300017T1 (de)
HR (1)	HRP980187B1 (de)
HU (1)	HUP9800802A3 (de)
ID (1)	ID20399A (de)
IL (1)	IL123961A (de)
NO (1)	NO323349B1 (de)
NZ (1)	NZ330131A (de)
PL (1)	PL187982B1 (de)
PT (1)	PT870508E (de)
RU (1)	RU2197264C2 (de)
SI (1)	SI0870508T1 (de)
SK (1)	SK282614B6 (de)
TR (1)	TR199800613A1 (de)
TW (1)	TW570803B (de)
UA (1)	UA42089C2 (de)
ZA (1)	ZA982915B (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20020038771A (ko) *	1999-09-24	2002-05-23	장 스테판느	비내 인플루엔자 바이러스 백신
GB9923176D0 (en) *	1999-09-30	1999-12-01	Smithkline Beecham Biolog	Novel composition
CN100415769C (zh) *	2002-02-07	2008-09-03	中国科学院过程工程研究所	寡聚或多聚亚基蛋白质分离纯化的方法
JP2005523722A (ja)	2002-04-30	2005-08-11	オンコリティクスバイオテック，インコーポレイティッド	改善されたウイルス精製方法
US20060110406A1 (en) *	2003-02-25	2006-05-25	Medimmune Vaccines, Inc.	Refrigerator-temperature stable influenza vaccine compositions
US7262045B2 (en) *	2003-02-25	2007-08-28	Medimmune Vaccines, Inc.	Methods of producing influenza vaccine compositions
ATE478137T1 (de) *	2003-06-20	2010-09-15	Microbix Biosystems Inc	Verbesserungen bei der virusproduktion
US8592197B2 (en)	2003-07-11	2013-11-26	Novavax, Inc.	Functional influenza virus-like particles (VLPs)
US8992939B2 (en)	2003-07-11	2015-03-31	Novavax, Inc.	Highly efficient influenza matrix (M1) proteins
US8080255B2 (en)	2003-07-11	2011-12-20	Novavax Inc.	Functional influenza virus like particles (VLPs)
US8506967B2 (en)	2003-07-11	2013-08-13	Novavax, Inc.	Functional influenza virus like particles (VLPs)
ES2329607T3 (es)	2004-02-23	2009-11-27	Crucell Holland B.V.	Metodos de purificacion de virus.
DE202005022108U1 (de)	2004-03-09	2013-11-12	Novartis Vaccines And Diagnostics, Inc.	Influenza-Virus-Impfstoffe
PT1789084E (pt)	2004-09-09	2011-02-22	Novartis Vaccines & Diagnostic	Redução de riscos iatrogénicos pontenciais associados às vacinas contra a gripe
US7901921B2 (en)	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
WO2006062637A2 (en)	2004-11-03	2006-06-15	Novartis Vaccines And Diagnostics Inc.	Influenza vaccination
DK2368975T3 (en) *	2004-12-23	2015-01-05	Medimmune Llc	Non-tumorigenic MDCK cell line for the propagation of viruses
PE20061428A1 (es)	2005-03-23	2007-01-16	Glaxosmithkline Biolog Sa	Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
US8574595B2 (en) *	2005-04-11	2013-11-05	Crucell Holland B.V.	Virus purification using ultrafiltration
WO2007052163A2 (en) *	2005-11-01	2007-05-10	Novartis Vaccines And Diagnostics Gmbh & Co Kg	Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment
US11707520B2 (en)	2005-11-03	2023-07-25	Seqirus UK Limited	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
US20090220541A1 (en) *	2005-11-04	2009-09-03	Novartis Vaccines And Diagnostics Srl	Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccines
WO2007052155A2 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
ES2377884T3 (es)	2005-11-04	2012-04-02	Novartis Vaccines And Diagnostics S.R.L.	Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
PL2368572T3 (pl)	2005-11-04	2020-11-16	Seqirus UK Limited	Szczepionki z adjuwantem z niewirionowymi antygenami otrzymane z wirusów grypy hodowanych w hodowli komórkowej
NZ567979A (en)	2005-11-04	2012-02-24	Novartis Vaccines & Diagnostic	Adjuvanted influenza vaccines including a cytokine-inducing agents which is an agonist of Toll-Like Receptor 7
BR122019013216B8 (pt)	2006-01-27	2021-07-27	Seqirus Uk Ltd	ensaio imunológico para análise de uma vacina contra influenza
JP2009534303A (ja)	2006-03-24	2009-09-24	ノバルティスヴァクシンズアンドダイアグノスティクスゲーエムベーハーアンドカンパニーカーゲー	冷蔵しないインフルエンザワクチンの保存
CN101472941B (zh)	2006-03-31	2017-08-08	沃弗-威斯康星校友研究基金会	用于疫苗的高滴度重组流感病毒
JP5639760B2 (ja)	2006-07-17	2014-12-10	グラクソスミスクラインバイオロジカルズソシエテアノニム	インフルエンザワクチン
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
EP3456348B1 (de)	2006-09-11	2025-03-26	Seqirus UK Limited	Herstellung von influenza-virus-impfstoffen ohne verwendung von eiern
KR101464783B1 (ko)	2006-09-15	2014-11-26	메디뮨 엘엘씨	높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
PL2121011T3 (pl)	2006-12-06	2014-10-31	Novartis Ag	Szczepionki zawierające antygeny czterech szczepów wirusa grypy
PL2114421T3 (pl) *	2007-03-05	2018-07-31	Om Pharma	Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
US20090060889A1 (en) *	2007-03-12	2009-03-05	Von Hofe Eric	Ii-RNAi involved Ii suppression in cancer immunotherapy
PE20090146A1 (es)	2007-04-20	2009-03-23	Glaxosmithkline Biolog Sa	Composicion inmunogenica contra el virus influenza
WO2008156778A2 (en)	2007-06-18	2008-12-24	Tokiko Watanabe	Influenza m2 protein mutant viruses as live influenza attenuated vaccines
CN101784283A (zh)	2007-06-27	2010-07-21	诺华有限公司	低添加流感疫苗
EP3058954B1 (de) *	2007-08-27	2017-03-01	Longhorn Vaccines and Diagnostics, LLC	Immunogene zusammensetzungen und verfahren
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
EP2268309B1 (de)	2008-03-18	2015-01-21	Novartis AG	Verbesserungen der herstellung von grippevirus-impstoff-antigenen
KR20110074564A (ko) *	2008-09-24	2011-06-30	메디뮨 엘엘씨	세포 배양, 바이러스 증식 및 바이러스 정제를 위한 방법
CA2741961A1 (en) *	2008-11-05	2010-05-14	Glaxosmithkline Biologicals S.A.	Novel method
ES2552383T3 (es)	2009-02-10	2015-11-27	Novartis Ag	Regímenes de vacuna de la gripe para cepas asociadas a pandemias
AU2010212548A1 (en)	2009-02-10	2011-09-15	Novartis Ag	Influenza vaccines with increased amounts of H3 antigen
AU2010212550B2 (en)	2009-02-10	2016-03-10	Seqirus UK Limited	Influenza vaccines with reduced amounts of squalene
FR2949344A1 (fr)	2009-04-27	2011-03-04	Novartis Ag	Vaccins de protection contre la grippe
EP2401384B1 (de)	2009-05-21	2012-10-03	Novartis AG	Reverse genetik unter verwendung nichtendogener pol-i-promotoren
WO2010144797A2 (en)	2009-06-12	2010-12-16	Vaccine Technologies, Incorporated	Influenza vaccines with enhanced immunogenicity and uses thereof
CA2803282C (en)	2009-07-06	2018-05-01	David E. Anderson	Methods for preparing vesicles and formulations produced therefrom
CN102482666B (zh)	2009-07-06	2017-02-08	变异生物技术公司	制备囊泡的方法和由其产生的制剂
EP2459722B1 (de)	2009-07-31	2017-09-06	Seqirus UK Limited	Reverse genetiksysteme
WO2011030218A1 (en)	2009-09-10	2011-03-17	Novartis Ag	Combination vaccines against respiratory tract diseases
WO2011048560A1 (en)	2009-10-20	2011-04-28	Novartis Ag	Improved reverse genetics methods for virus rescue
JP2013507990A (ja)	2009-10-26	2013-03-07	ダブリュエーアールエフ−ウィスコンシンアラムナイリサーチファウンデーション	ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
US10130697B2 (en)	2010-03-23	2018-11-20	Wisconsin Alumni Research Foundation (Warf)	Vaccines comprising mutant attenuated influenza viruses
US8945904B2 (en)	2010-05-21	2015-02-03	Novartis Ag	Influenza virus reassortment
KR102113512B1 (ko)	2010-06-01	2020-05-22	노파르티스 아게	동결건조하지 않는 인플루엔자 백신 항원의 농축
CN102939104A (zh)	2010-06-01	2013-02-20	诺华有限公司	用冻干浓缩疫苗抗原
CN103096922B (zh)	2010-07-06	2019-08-06	变异生物技术公司	用于治疗流行性感冒的组合物和方法
ES2531577T3 (es)	2010-08-20	2015-03-17	Novartis Ag	Conjuntos de agujas para la administración de vacuna soluble contra la gripe
US20130323280A1 (en)	2011-01-13	2013-12-05	Variation Biotechnologies, Inc.	Methods for preparing vesicles and formulations produced therefrom
BR112013017939B1 (pt)	2011-01-13	2022-11-16	Variation Biotechnologies Inc	Composição imunogênica liofilizada termoestável, uso e método para preparação da mesma
ES2655051T3 (es)	2011-08-26	2018-02-16	Wisconsin Alumni Research Foundation	Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
US20140248320A1 (en)	2011-10-20	2014-09-04	Novartis Ag	Adjuvanted influenza b virus vaccines for pediatric priming
US20140328876A1 (en)	2011-11-18	2014-11-06	Variation Biotechnologies Inc.	Synthetic derivatives of mpl and uses thereof
EP2802353A4 (de)	2012-01-12	2015-12-02	Variation Biotechnologies Inc	Zusammensetzungen und verfahren zur behandlung von virusinfektionen
CN104244984B (zh)	2012-01-27	2020-03-31	变异生物技术公司	用于治疗剂的方法和组合物
JP6054883B2 (ja)	2012-03-02	2016-12-27	ノバルティスアーゲー	インフルエンザウイルスの再集合
EP2855701A1 (de)	2012-06-04	2015-04-08	Novartis AG	Verbesserte sicherheitsprüfung
GB201218195D0 (en)	2012-10-10	2012-11-21	Istituto Zooprofilattico Sperimentale Delle Venezie	Composition
CA2893429A1 (en)	2012-12-03	2014-06-12	Synthetic Genomics Vaccines, Inc.	Influenza virus reassortment
MX372963B (es)	2013-03-13	2020-04-01	Seqirus Uk Ltd	Reordenamiento del virus de influenza b.
SG11201509265SA (en)	2013-05-10	2015-12-30	Novartis Ag	Avoiding narcolepsy risk in influenza vaccines
DE202013005130U1 (de)	2013-06-05	2013-09-10	Novartis Ag	Influenza Virus Reassortierung
DE202013005100U1 (de)	2013-06-05	2013-08-26	Novartis Ag	Influenza Virus Reassortierung
CA2914604A1 (en)	2013-06-06	2014-12-11	Novartis Ag	Influenza virus reassortment
WO2015009743A1 (en)	2013-07-15	2015-01-22	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
RU2535153C1 (ru) *	2013-09-04	2014-12-10	Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства России (ФГУП СПбНИИВС ФМБА России)	Способ получения высокоочищенных вирионных концентратов
AU2014350370B2 (en) *	2013-11-15	2017-04-13	Novartis Ag	Removal of residual cell culture impurities
WO2015196150A2 (en)	2014-06-20	2015-12-23	Wisconsin Alumni Research Foundation (Warf)	Mutations that confer genetic stability to additional genes in influenza viruses
EP2966093A1 (de)	2014-07-07	2016-01-13	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Verfahren zur Herstellung von magnetischen sulfatierten Celluloseteilchen, magnetische sulfatierte Celluloseteilchen und ihre Anwendung
US10633422B2 (en)	2015-06-01	2020-04-28	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
RU2614127C2 (ru) *	2015-06-04	2017-03-22	Общество с ограниченной ответственностью "НТфарма"	Способ получения концентрата рекомбинантных псевдоаденовирусных частиц, экспрессирующих ген гемагглютинина вируса гриппа A/California/07/2009(H1N1)
KR20180035807A (ko)	2015-06-26	2018-04-06	세퀴러스 유케이 리미티드	항원적으로 매치된 인플루엔자 백신
WO2017007839A1 (en)	2015-07-06	2017-01-12	Wisconsin Alumni Research Foundation (Warf)	Improved influenza virus replication for vaccine development
WO2017005880A1 (en)	2015-07-07	2017-01-12	Seqirus UK Limited	Influenza potency assays
CN109477074B (zh)	2016-02-19	2023-01-24	威斯康星旧生研究基金会	用于疫苗开发的改进的乙型流感病毒复制
US11268071B2 (en)	2017-03-30	2022-03-08	Merck Sharp And Dohme Corp.	Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids
WO2019084310A1 (en)	2017-10-25	2019-05-02	Yoshihiro Kawaoka	HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
RU2670001C1 (ru) *	2017-12-25	2018-10-17	Федеральное государственное бюджетное учреждение науки Институт биохимии и физиологии растений и микроорганизмов Российской академии наук	Способ получения белков клеточной поверхности
EP3737750B1 (de)	2018-01-09	2024-06-05	Theriva Biologics, Inc.	Alkalische phosphatasemittel zur behandlung von entwicklungsstörungen des nervensystems
WO2019183209A1 (en)	2018-03-20	2019-09-26	Synthetic Biologics, Inc.	Alkaline phosphatase agents for treatment of radiation disorders
ES3032290T3 (en)	2018-03-20	2025-07-16	Theriva Biologics Inc	Intestinal alkaline phosphatase formulations
JP7783047B2 (ja)	2018-08-07	2025-12-09	ウィスコンシンアルムニリサーチファンデイション	組換えの生物学的に封じ込められたフィロウイルスワクチン
EP3840780A1 (de)	2018-08-20	2021-06-30	Wisconsin Alumni Research Foundation	Vektoren zur auslösung von immunantworten auf nicht-dominante epitope im hämagglutinin (ha)-protein
WO2020167432A2 (en)	2019-01-23	2020-08-20	Yoshihiro Kawaoka	Mutations that confer genetic stability to additional genes in influenza viruses
WO2020163804A1 (en)	2019-02-08	2020-08-13	Wisconsin Alumni Research Foundation (Warf)	Humanized cell line
CN114929269A (zh)	2019-05-01	2022-08-19	威斯康星校友研究基金会(Warf)	用于疫苗开发的改进的流感病毒复制
KR20220005560A (ko)	2019-05-06	2022-01-13	신세틱 바이오로직스, 인코퍼레이티드	알칼리성 포스페이트-기반 종양학 치료제
JP7627911B2 (ja)	2019-08-27	2025-02-07	ウィスコンシンアルムニリサーチファンデイション	卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
BR112022008711A2 (pt) *	2019-11-07	2022-07-19	Seqirus Uk Ltd	Métodos para produzir uma vacina viral e reduzir o tamanho da partícula viral
IL293031A (en)	2019-11-18	2022-07-01	Seqirus Pty Ltd	A method for producing reassortant influenza viruses
EP4093415A1 (de)	2020-01-24	2022-11-30	Wisconsin Alumni Research Foundation (WARF)	Rekombinante influenza-viren mit stabilisiertem na
US12290562B2 (en)	2020-03-25	2025-05-06	Wisconsin Alumni Research Foundation (Warf)	Recombinant multivalent influenza viruses
KR102444684B1 (ko) *	2020-04-29	2022-09-16	에스케이바이오사이언스(주)	일회용 배양 공정 시스템을 이용한 인플루엔자 바이러스 생산 방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH589453A5 (de) *	1974-01-14	1977-07-15	Sandoz Ag
SU487541A1 (ru) *	1974-05-22	1976-03-25	Всесоюзный научно-исследовательский институт гриппа	Способ получени препаратов вируса гриппа
US4500513A (en) *	1979-05-15	1985-02-19	Miles Laboratories, Inc.	Influenza vaccine production in liquid cell culture
US4317811A (en) *	1980-09-11	1982-03-02	Merck & Co., Inc.	Herpes simplex type 1 subunit vaccine
DE3237313A1 (de) *	1982-10-08	1984-04-12	Werner Heese	Verfahren zur gewinnung und reinigung antigenhaltiger loesungen, insbesondere fuer influenza-viren, aus antigenhaltiger allantoisfluessigkeit
US4783411A (en) *	1984-10-22	1988-11-08	Janis Gabliks	Influenza-A virus vaccine from fish cell cultures
US5173418A (en) *	1985-05-10	1992-12-22	Benzon Pharma, A/S	Production in Escherichia coli of extracellular Serratia spp. hydrolases
US5006472A (en) *	1988-06-03	1991-04-09	Miles Inc.	Enzymatic purification process
EP0408742B1 (de) *	1989-02-07	1994-09-28	Bio-Technology General Corporation	Verfahren zur herstellung und reinigung von hepatitis b-impfstoff
EP0389925B1 (de) *	1989-03-29	1995-12-27	The Research Foundation Of State University Of New York	Verfahren zur Reinigungbvon Aussenmembran-Protein von Haemophilus influenzae
US5643577A (en) *	1990-04-24	1997-07-01	The University Of Newcastle Research Associates Limited	Oral vaccine comprising antigen surface-associated with red blood cells
DZ1706A1 (fr) *	1992-08-07	2002-02-17	Merck & Co Inc	Vaccin contre le virus de l'hepatite a.
RU2082431C1 (ru) *	1993-05-12	1997-06-27	Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им.Пастера	Способ получения инактивированной гриппозной вакцины
HRP950097A2 (en) *	1994-03-08	1997-06-30	Merck & Co Inc	Hepatitis a virus culture process
US5612037A (en) *	1994-07-26	1997-03-18	Connaught Laboratories, Inc.	Influenza virus subunit conjugates
ATE542891T1 (de) *	1994-11-10	2012-02-15	Baxter Healthcare Sa	Verfahren zur herstellung von biologischen produkten in protein-freier kultur
US5681746A (en) *	1994-12-30	1997-10-28	Chiron Viagene, Inc.	Retroviral delivery of full length factor VIII
DE69626022T3 (de) *	1995-08-01	2008-05-08	Sanofi Pasteur	Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
AU716497B2 (en) *	1995-09-28	2000-02-24	Dana-Farber Cancer Institute	Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
RU2100033C1 (ru) *	1995-10-05	1997-12-27	Санкт-Петербургский научно-исследовательский институт вакцин и сывороток	Способ получения вакцинных штаммов вируса гриппа в для производства инактивированных и живых гриппозных вакцин
RU2080124C1 (ru) *	1995-10-19	1997-05-27	Санкт-Петербургский научно-исследовательский институт вакцин и сывороток	Способ получения живой гриппозной вакцины
RU2164148C1 (ru) *	2000-08-09	2001-03-20	Петров Рэм Викторович	Вакцина против вируса гриппа и способ ее получения

1998
- 1998-04-01 TW TW087104913A patent/TW570803B/zh not_active IP Right Cessation
- 1998-04-02 DE DE69800383T patent/DE69800383T2/de not_active Expired - Lifetime
- 1998-04-02 EP EP98201056A patent/EP0870508B1/de not_active Revoked
- 1998-04-02 AT AT98201056T patent/ATE197406T1/de active
- 1998-04-02 ES ES98201056T patent/ES2129386T3/es not_active Expired - Lifetime
- 1998-04-02 DK DK98201056T patent/DK0870508T3/da active
- 1998-04-02 PT PT98201056T patent/PT870508E/pt unknown
- 1998-04-02 DE DE0870508T patent/DE870508T1/de active Pending
- 1998-04-02 TR TR1998/00613A patent/TR199800613A1/xx unknown
- 1998-04-02 SI SI9830010T patent/SI0870508T1/xx unknown
- 1998-04-06 CZ CZ0105098A patent/CZ297492B6/cs unknown
- 1998-04-06 CN CNB981080863A patent/CN1138564C/zh not_active Expired - Lifetime
- 1998-04-06 RU RU98106860/13A patent/RU2197264C2/ru active
- 1998-04-06 DZ DZ980072A patent/DZ2462A1/xx active
- 1998-04-06 SK SK445-98A patent/SK282614B6/sk not_active IP Right Cessation
- 1998-04-06 ZA ZA982915A patent/ZA982915B/xx unknown
- 1998-04-06 US US09/055,321 patent/US5948410A/en not_active Expired - Lifetime
- 1998-04-06 KR KR1019980012018A patent/KR100593235B1/ko not_active Expired - Lifetime
- 1998-04-06 BR BR9801015-8A patent/BR9801015A/pt not_active Application Discontinuation
- 1998-04-06 ID IDP980519A patent/ID20399A/id unknown
- 1998-04-06 HR HR980187A patent/HRP980187B1/xx not_active IP Right Cessation
- 1998-04-06 CA CA002234208A patent/CA2234208C/en not_active Expired - Lifetime
- 1998-04-06 AU AU60659/98A patent/AU728939B2/en not_active Expired
- 1998-04-06 PL PL98325722A patent/PL187982B1/pl unknown
- 1998-04-06 NZ NZ330131A patent/NZ330131A/en not_active IP Right Cessation
- 1998-04-06 IL IL12396198A patent/IL123961A/xx not_active IP Right Cessation
- 1998-04-06 NO NO981557A patent/NO323349B1/no not_active IP Right Cessation
- 1998-04-06 HU HU9800802A patent/HUP9800802A3/hu not_active Application Discontinuation
- 1998-04-07 JP JP11010198A patent/JP5258127B2/ja not_active Expired - Lifetime
- 1998-04-08 UA UA98041787A patent/UA42089C2/uk unknown
- 1998-04-08 AR ARP980101611A patent/AR011216A1/es not_active Application Discontinuation
1999
- 1999-01-01 GR GR990300017T patent/GR990300017T1/el unknown
2000
- 2000-11-09 GR GR20000402476T patent/GR3034798T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
AR011216A1 (es)	2000-08-02
KR100593235B1 (ko)	2007-12-04
AU728939B2 (en)	2001-01-18
DZ2462A1 (fr)	2003-01-18
EP0870508A1 (de)	1998-10-14
PT870508E (pt)	2001-04-30
DE69800383D1 (de)	2000-12-14
HRP980187B1 (en)	2001-04-30
TW570803B (en)	2004-01-11
DE69800383T2 (de)	2001-08-16
CA2234208A1 (en)	1998-10-09
HRP980187A2 (en)	1999-04-30
SI0870508T1 (en)	2001-02-28
SK44598A3 (en)	1998-11-04
NO981557D0 (no)	1998-04-06
CZ297492B6 (cs)	2007-01-03
MX9802766A (es)	1998-12-31
CA2234208C (en)	2003-06-10
EP0870508B1 (de)	2000-11-08
HK1010833A1 (en)	1999-07-02
HUP9800802A2 (hu)	1999-04-28
ATE197406T1 (de)	2000-11-11
SK282614B6 (sk)	2002-10-08
RU2197264C2 (ru)	2003-01-27
KR19980081114A (ko)	1998-11-25
US5948410A (en)	1999-09-07
ES2129386T3 (es)	2001-01-01
GR3034798T3 (en)	2001-02-28
CN1138564C (zh)	2004-02-18
CN1196956A (zh)	1998-10-28
GR990300017T1 (en)	1999-06-30
PL325722A1 (en)	1998-10-12
CZ105098A3 (cs)	1998-10-14
JPH1121253A (ja)	1999-01-26
ES2129386T1 (es)	1999-06-16
NO323349B1 (no)	2007-04-02
DE870508T1 (de)	1999-08-19
PL187982B1 (pl)	2004-11-30
JP5258127B2 (ja)	2013-08-07
BR9801015A (pt)	2000-01-11
IL123961A (en)	2000-07-16
HU9800802D0 (en)	1998-05-28
NZ330131A (en)	1999-10-28
AU6065998A (en)	1998-10-15
NO981557L (no)	1998-10-12
ID20399A (id)	1998-12-10
UA42089C2 (uk)	2001-10-15
HUP9800802A3 (en)	2003-08-28
TR199800613A1 (xx)	1998-10-21
ZA982915B (en)	1999-01-21

Publication	Publication Date	Title
ATE197406T1 (de)	2000-11-11	Influenza vaccine
NO20003303L (no)	2000-08-04	Vaksine
NO996133D0 (no)	1999-12-10	Olje-i-vann-vaksinesammensetninger
NO20014323D0 (no)	2001-09-05	Vaksine
BR9711853A (pt)	1999-08-24	Vacinas
NO20006191D0 (no)	2000-12-06	Vaksine
DE69727923D1 (de)	2004-04-08	Gehhilfe
DE60002650D1 (de)	2003-06-18	Öladjuvierter Impfstoff
NO20020763D0 (no)	2002-02-15	Vaksine
FI970277L (fi)	1997-01-23	Influenssavirusalayksikön konjugaatteja
EP0967993A4 (de)	2001-04-18	Anti-kokaine vakzine
DK0898969T3 (da)	2005-01-17	Neospora-vaccine
NO20005599D0 (no)	2000-11-06	Vaksine
DE69820648D1 (de)	2004-01-29	Gehhilfe
ATE431415T1 (de)	2009-05-15	Hiv impfstoff
ID23663A (id)	2000-05-11	Persiapan kaprolaktam
ITMI981384A0 (it)	1998-06-17	Vaccino per hiv
BR1100968A (pt)	2002-04-09	Formulação de vacina de subunidade